{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:03:31Z","timestamp":1788897811502,"version":"build-2803163510"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12161-7","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:42:09Z","timestamp":1782859329000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multi-omics approaches to parkinsonism: genomic, proteomic, and non-coding RNA perspectives"],"prefix":"10.1007","volume":"53","author":[{"given":"S.","family":"Anusha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharanappa","family":"Gurikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. B.","family":"Kavyashree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahana","family":"Nagaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharathi Doddla","family":"Raghunathanaidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Sagheer","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"issue":"15","key":"12161_CR1","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3390\/cells14151161","volume":"14","author":"M Tanaka","year":"2025","unstructured":"Tanaka M (2025) Parkinson\u2019s Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation. Cells 14(15):1161. https:\/\/doi.org\/10.3390\/cells14151161","journal-title":"Cells"},{"issue":"11","key":"12161_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1212\/WNL.0000000000010496","volume":"95","author":"G Lamotte","year":"2020","unstructured":"Lamotte G, Becker B (2020) Toward biomarker-based clinical subtyping of Parkinson disease. Neurology 95(11):461\u2013462. https:\/\/doi.org\/10.1212\/WNL.0000000000010496","journal-title":"Neurology"},{"issue":"9","key":"12161_CR3","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.3390\/biomedicines10092278","volume":"10","author":"VV Goloborshcheva","year":"2022","unstructured":"Goloborshcheva VV, Kucheryanu VG, Voronina NA, Teterina EV, Ustyugov AA, Morozov SG (2022) Synuclein Proteins in MPTP-Induced Death of Substantia Nigra Pars Compacta Dopaminergic Neurons. Biomedicines 10(9):2278. https:\/\/doi.org\/10.3390\/biomedicines10092278","journal-title":"Biomedicines"},{"issue":"1","key":"12161_CR4","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1038\/s41467-024-49949-9","volume":"15","author":"A Zarkali","year":"2024","unstructured":"Zarkali A, Thomas GEC, Zetterberg H, Weil RS (2024) Neuroimaging and fluid biomarkers in Parkinson\u2019s disease in an era of targeted interventions. Nat Commun 15(1):5661. https:\/\/doi.org\/10.1038\/s41467-024-49949-9","journal-title":"Nat Commun"},{"key":"12161_CR5","doi-asserted-by":"publisher","unstructured":"Kumar S, Goyal L, Singh S (2022) Tremor and Rigidity in Patients with Parkinson\u2019s Disease: Emphasis onEpidemiology, Pathophysiology and Contributing Factors. CNS & Neurological Disorders - Drug Targets, 21(7), 596\u2013609. https:\/\/doi.org\/10.2174\/1871527320666211006142100","DOI":"10.2174\/1871527320666211006142100"},{"issue":"1","key":"12161_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s42466-024-00309-4","volume":"6","author":"C Daniels","year":"2024","unstructured":"Daniels C, Rodr\u00edguez-Antig\u00fcedad J, Jentschke E, Kulisevsky J, Volkmann J (2024) Cognitive disorders in advanced Parkinson\u2019s disease: challenges in the diagnosis of delirium. Neurol Res Pract 6(1):14. https:\/\/doi.org\/10.1186\/s42466-024-00309-4","journal-title":"Neurol Res Pract"},{"issue":"5","key":"12161_CR7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W (2021) Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol 20(5):385\u2013397. https:\/\/doi.org\/10.1016\/S1474-4422(21)00030-2","journal-title":"Lancet Neurol"},{"issue":"1","key":"12161_CR8","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s11033-025-10929-x","volume":"52","author":"P Sharma","year":"2025","unstructured":"Sharma P, Dhamija RK (2025) The quest for Parkinson\u2019s disease biomarkers: traditional and emerging multi-omics approaches. Mol Biol Rep 52(1):831. https:\/\/doi.org\/10.1007\/s11033-025-10929-x","journal-title":"Mol Biol Rep"},{"issue":"2","key":"12161_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3390\/biom10020335","volume":"10","author":"F Paolini Paoletti","year":"2020","unstructured":"Paolini Paoletti F, Gaetani L, Parnetti L (2020) The Challenge of Disease-Modifying Therapies in Parkinson\u2019s Disease: Role of CSF Biomarkers. Biomolecules 10(2):335. https:\/\/doi.org\/10.3390\/biom10020335","journal-title":"Biomolecules"},{"issue":"2","key":"12161_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/bfgp\/elac017","volume":"22","author":"MA Dar","year":"2023","unstructured":"Dar MA, Arafah A, Bhat KA, Khan A, Khan MS, Ali A, Rehman MU (2023) Multiomics technologies: role in disease biomarker discoveries and therapeutics. Brief Funct Genomics 22(2):76\u201396. https:\/\/doi.org\/10.1093\/bfgp\/elac017","journal-title":"Brief Funct Genomics"},{"issue":"6","key":"12161_CR11","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS (2020) Diagnosis and Treatment of Parkinson Disease: A Review. JAMA 323(6):548. https:\/\/doi.org\/10.1001\/jama.2019.22360","journal-title":"JAMA"},{"issue":"10291","key":"12161_CR12","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. Lancet 397(10291):2284\u20132303. https:\/\/doi.org\/10.1016\/S0140-6736(21)00218-X","journal-title":"Lancet"},{"issue":"3","key":"12161_CR13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/bcpt.14042","volume":"135","author":"RK Tuominen","year":"2024","unstructured":"Tuominen RK, Renko J (2024) Biomarkers of Parkinson\u2019s disease in perspective of early diagnosis and translation of neurotrophic therapies. Basic Clin Pharmacol Toxicol 135(3):271\u2013284. https:\/\/doi.org\/10.1111\/bcpt.14042","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"10291","key":"12161_CR14","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. Lancet 397(10291):2284\u20132303. https:\/\/doi.org\/10.1016\/S0140-6736(21)00218-X","journal-title":"Lancet"},{"key":"12161_CR15","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1016\/j.parkreldis.2015.09.048","volume":"22","author":"M Delenclos","year":"2016","unstructured":"Delenclos M, Jones DR, McLean PJ, Uitti RJ (2016) Biomarkers in Parkinson\u2019s disease: Advances and strategies. Parkinsonism Relat Disord 22:S106\u2013S110. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.09.048","journal-title":"Parkinsonism Relat Disord"},{"key":"12161_CR16","doi-asserted-by":"publisher","first-page":"100074","DOI":"10.1016\/j.bionps.2023.100074","volume":"9","author":"KY Yamashita","year":"2023","unstructured":"Yamashita KY, Bhoopatiraju S, Silverglate BD, Grossberg GT (2023) Biomarkers in Parkinson\u2019s disease: A state of the art review. Biomarkers Neuropsychiatry 9:100074. https:\/\/doi.org\/10.1016\/j.bionps.2023.100074","journal-title":"Biomarkers Neuropsychiatry"},{"issue":"10","key":"12161_CR17","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1001\/jamaneurol.2021.1312","volume":"78","author":"T Mitchell","year":"2021","unstructured":"Mitchell T, Leh\u00e9ricy S, Chiu SY, Strafella AP, Stoessl AJ, Vaillancourt DE (2021) Emerging Neuroimaging Biomarkers Across Disease Stage in Parkinson Disease: A Review. JAMA Neurol 78(10):1262. https:\/\/doi.org\/10.1001\/jamaneurol.2021.1312","journal-title":"JAMA Neurol"},{"issue":"6","key":"12161_CR18","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/s44321-025-00229-z","volume":"17","author":"M Schuler","year":"2025","unstructured":"Schuler M, Gerwert G, Mann M, Woitzik N, Langenhoff L, Hubert D, Gerwert K (2025) Alpha-synuclein misfolding as fluid biomarker for Parkinson\u2019s disease measured with the iRS platform. EMBO Mol Med 17(6):1203\u20131221. https:\/\/doi.org\/10.1038\/s44321-025-00229-z","journal-title":"EMBO Mol Med"},{"issue":"9","key":"12161_CR19","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s00702-022-02498-1","volume":"129","author":"L T\u00f6nges","year":"2022","unstructured":"T\u00f6nges L, Buhmann C, Klebe S, Klucken J, Kwon EH, M\u00fcller T, Lingor P (2022) Blood-based biomarker in Parkinson\u2019s disease: potential for future applications in clinical research and practice. J Neural Transm 129(9):1201\u20131217. https:\/\/doi.org\/10.1007\/s00702-022-02498-1","journal-title":"J Neural Transm"},{"issue":"6","key":"12161_CR20","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00702-023-02632-7","volume":"130","author":"C Buhmann","year":"2023","unstructured":"Buhmann C, Magnus T, Choe C (2023) Blood neurofilament light chain in Parkinson\u2019s disease. J Neural Transm 130(6):755\u2013762. https:\/\/doi.org\/10.1007\/s00702-023-02632-7","journal-title":"J Neural Transm"},{"key":"12161_CR21","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.expneurol.2017.08.007","volume":"297","author":"Y-L Sheng","year":"2017","unstructured":"Sheng Y-L, Chen X, Hou X-O, Yuan X, Yuan B-S, Yuan Y-Q, Hu L-F (2017) Urate promotes SNCA\/\u03b1-synuclein clearance via regulating mTOR-dependent macroautophagy. Exp Neurol 297:138\u2013147. https:\/\/doi.org\/10.1016\/j.expneurol.2017.08.007","journal-title":"Exp Neurol"},{"issue":"1","key":"12161_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41531-023-00568-z","volume":"9","author":"M Tsalenchuk","year":"2023","unstructured":"Tsalenchuk M, Gentleman SM, Marzi SJ (2023) Linking environmental risk factors with epigenetic mechanisms in Parkinson\u2019s disease. npj Parkinson\u2019s Disease 9(1):123. https:\/\/doi.org\/10.1038\/s41531-023-00568-z","journal-title":"npj Parkinson\u2019s Disease"},{"issue":"2","key":"12161_CR23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","volume":"19","author":"C Blauwendraat","year":"2020","unstructured":"Blauwendraat C, Nalls MA, Singleton AB (2020) The genetic architecture of Parkinson\u2019s disease. Lancet Neurol 19(2):170\u2013178. https:\/\/doi.org\/10.1016\/S1474-4422(19)30287-X","journal-title":"Lancet Neurol"},{"issue":"3","key":"12161_CR24","doi-asserted-by":"publisher","first-page":"100153","DOI":"10.1016\/j.neurop.2024.100153","volume":"4","author":"P Salles","year":"2024","unstructured":"Salles P, Tirapegui JM, Chan\u00e1-Cuevas P (2024) Genetics of Parkinson\u2019s disease: Dominant forms and GBA. Neurol Perspect 4(3):100153. https:\/\/doi.org\/10.1016\/j.neurop.2024.100153","journal-title":"Neurol Perspect"},{"issue":"11","key":"12161_CR25","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1002\/mdc3.14206","volume":"11","author":"F Arienti","year":"2024","unstructured":"Arienti F, Casazza G, Franco G, Lazzeri G, Monfrini E, Di Maio A, Di Fonzo A (2024) Family History in Parkinson\u2019s Disease: A National Cross-Sectional Study. Mov Disorders Clin Pract 11(11):1434\u20131440. https:\/\/doi.org\/10.1002\/mdc3.14206","journal-title":"Mov Disorders Clin Pract"},{"issue":"3","key":"12161_CR26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.5603\/PJNNS.a2021.0013","volume":"55","author":"\u0141M Milanowski","year":"2021","unstructured":"Milanowski \u0141M, Ross OA, Friedman A, Hoffman-Zacharska D, Gorka-Skoczylas P, Jurek M, Wszolek ZK (2021) Genetics of Parkinson\u2019s disease in the Polish population. Neurol Neurochir Pol 55(3):241\u2013252. https:\/\/doi.org\/10.5603\/PJNNS.a2021.0013","journal-title":"Neurol Neurochir Pol"},{"key":"12161_CR27","doi-asserted-by":"publisher","first-page":"1023574","DOI":"10.3389\/fnagi.2022.1023574","volume":"14","author":"J Dulski","year":"2022","unstructured":"Dulski J, Uitti RJ, Ross OA, Wszolek ZK (2022) Genetic architecture of Parkinson\u2019s disease subtypes \u2013 Review of the literature. Front Aging Neurosci 14:1023574. https:\/\/doi.org\/10.3389\/fnagi.2022.1023574","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"12161_CR28","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.3390\/genes12071006","volume":"12","author":"JO Day","year":"2021","unstructured":"Day JO, Mullin S (2021) The Genetics of Parkinson\u2019s Disease and Implications for Clinical Practice. Genes 12(7):1006. https:\/\/doi.org\/10.3390\/genes12071006","journal-title":"Genes"},{"issue":"10","key":"12161_CR29","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1038\/s41436-020-0851-0","volume":"22","author":"SA Rasmussen","year":"2020","unstructured":"Rasmussen SA, Hamosh A, Amberger J, Arnold C, Bocchini C, O\u2018Neill MJF, Stumpf A (2020) What\u2019s in a name? Issues to consider when naming Mendelian disorders. Genet Sci 22(10):1573\u20131575. https:\/\/doi.org\/10.1038\/s41436-020-0851-0","journal-title":"Genet Sci"},{"issue":"3","key":"12161_CR30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.5603\/PJNNS.a2021.0013","volume":"55","author":"\u0141M Milanowski","year":"2021","unstructured":"Milanowski \u0141M, Ross OA, Friedman A, Hoffman-Zacharska D, Gorka-Skoczylas P, Jurek M, Wszolek ZK (2021) Genetics of Parkinson\u2019s disease in the Polish population. Neurol Neurochir Pol 55(3):241\u2013252. https:\/\/doi.org\/10.5603\/PJNNS.a2021.0013","journal-title":"Neurol Neurochir Pol"},{"issue":"12","key":"12161_CR31","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.3390\/biomedicines10123241","volume":"10","author":"A Surguchov","year":"2022","unstructured":"Surguchov A, Surguchev A (2022) Synucleins: New Data on Misfolding, Aggregation and Role in Diseases. Biomedicines 10(12):3241. https:\/\/doi.org\/10.3390\/biomedicines10123241","journal-title":"Biomedicines"},{"key":"12161_CR32","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.69450","author":"A Jahabardeen","year":"2024","unstructured":"Jahabardeen A, S, N., J, N., V C (2024) A Review on the Role of SNCA Gene in Neurodegenerative Diseases. Cureus. https:\/\/doi.org\/10.7759\/cureus.69450","journal-title":"Cureus"},{"issue":"6","key":"12161_CR33","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s13760-020-01473-5","volume":"120","author":"A Cherian","year":"2020","unstructured":"Cherian A, Divya KP (2020) Genetics of Parkinson\u2019s disease. Acta Neurol Belgica 120(6):1297\u20131305. https:\/\/doi.org\/10.1007\/s13760-020-01473-5","journal-title":"Acta Neurol Belgica"},{"issue":"5","key":"12161_CR34","doi-asserted-by":"publisher","first-page":"e00660","DOI":"10.1128\/MCB.00660-20","volume":"41","author":"A Usmani","year":"2021","unstructured":"Usmani A, Shavarebi F, Hiniker A (2021) The Cell Biology of LRRK2 in Parkinson\u2019s Disease. Mol Cell Biol 41(5):e00660\u2013e00620. https:\/\/doi.org\/10.1128\/MCB.00660-20","journal-title":"Mol Cell Biol"},{"issue":"3","key":"12161_CR35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.5607\/en.2018.27.3.171","volume":"27","author":"DH Ho","year":"2018","unstructured":"Ho DH, Je AR, Lee H, Son I, Kweon H-S, Kim H-G, Seol W (2018) LRRK2 Kinase Activity Induces Mitochondrial Fission in Microglia via Drp1 and Modulates Neuroinflammation. Experimental Neurobiol 27(3):171\u2013180. https:\/\/doi.org\/10.5607\/en.2018.27.3.171","journal-title":"Experimental Neurobiol"},{"key":"12161_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/8610285","volume":"2021","author":"A Planas-Ballv\u00e9","year":"2021","unstructured":"Planas-Ballv\u00e9 A, Vilas D (2021) Cognitive Impairment in Genetic Parkinson\u2019s Disease. Parkinson\u2019s Disease 2021:1\u201311. https:\/\/doi.org\/10.1155\/2021\/8610285","journal-title":"Parkinson\u2019s Disease"},{"key":"12161_CR37","doi-asserted-by":"publisher","first-page":"102720","DOI":"10.1016\/j.conb.2023.102720","volume":"80","author":"SL Pereira","year":"2023","unstructured":"Pereira SL, Grossmann D, Delcambre S, Hermann A, Gr\u00fcnewald A (2023) Novel insights into Parkin-mediated mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease. Curr Opin Neurobiol 80:102720. https:\/\/doi.org\/10.1016\/j.conb.2023.102720","journal-title":"Curr Opin Neurobiol"},{"key":"12161_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neures.2020.09.001","volume":"159","author":"K Wasner","year":"2020","unstructured":"Wasner K, Gr\u00fcnewald A, Klein C (2020) Parkin-linked Parkinson\u2019s disease: From clinical insights to pathogenic mechanisms and novel therapeutic approaches. Neurosci Res 159:34\u201339. https:\/\/doi.org\/10.1016\/j.neures.2020.09.001","journal-title":"Neurosci Res"},{"issue":"16","key":"12161_CR39","doi-asserted-by":"publisher","first-page":"5724","DOI":"10.3390\/ijms21165724","volume":"21","author":"CA Morato Torres","year":"2020","unstructured":"Morato Torres CA, Wassouf Z, Zafar F, Sastre D, Outeiro TF, Sch\u00fcle B (2020) The Role of Alpha-Synuclein and Other Parkinson\u2019s Genes in Neurodevelopmental and Neurodegenerative Disorders. Int J Mol Sci 21(16):5724. https:\/\/doi.org\/10.3390\/ijms21165724","journal-title":"Int J Mol Sci"},{"issue":"11","key":"12161_CR40","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.3390\/cells10113022","volume":"10","author":"M Vizziello","year":"2021","unstructured":"Vizziello M, Borellini L, Franco G, Ardolino G (2021) Disruption of Mitochondrial Homeostasis: The Role of PINK1 in Parkinson\u2019s Disease. Cells 10(11):3022. https:\/\/doi.org\/10.3390\/cells10113022","journal-title":"Cells"},{"issue":"1","key":"12161_CR41","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s40478-020-01062-w","volume":"8","author":"PMJ Quinn","year":"2020","unstructured":"Quinn PMJ, Moreira PI, Ambr\u00f3sio AF, Alves CH (2020) PINK1\/PARKIN signalling in neurodegeneration and neuroinflammation. Acta Neuropathol Commun 8(1):189. https:\/\/doi.org\/10.1186\/s40478-020-01062-w","journal-title":"Acta Neuropathol Commun"},{"key":"12161_CR42","doi-asserted-by":"publisher","first-page":"111277","DOI":"10.1016\/j.mad.2020.111277","volume":"189","author":"F Brunelli","year":"2020","unstructured":"Brunelli F, Valente EM, Arena G (2020) Mechanisms of neurodegeneration in Parkinson\u2019s disease: keep neurons in the PINK1. Mech Ageing Dev 189:111277. https:\/\/doi.org\/10.1016\/j.mad.2020.111277","journal-title":"Mech Ageing Dev"},{"issue":"9","key":"12161_CR43","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/jcm8091377","volume":"8","author":"M Repici","year":"2019","unstructured":"Repici M, Giorgini F (2019) DJ-1 in Parkinson\u2019s Disease: Clinical Insights and Therapeutic Perspectives. J Clin Med 8(9):1377. https:\/\/doi.org\/10.3390\/jcm8091377","journal-title":"J Clin Med"},{"issue":"7","key":"12161_CR44","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.4103\/NRR.NRR-D-24-01047","volume":"21","author":"A Zhao","year":"2026","unstructured":"Zhao A, Ding Y, Zhong M, Niu M, Wang L, Jiao Y, Li Y (2026) Neuronal DJ-1 regulates microglial activation in Parkinson\u2019s disease. Neural Regeneration Res 21(7):3130\u20133138. https:\/\/doi.org\/10.4103\/NRR.NRR-D-24-01047","journal-title":"Neural Regeneration Res"},{"key":"12161_CR45","doi-asserted-by":"publisher","first-page":"105056","DOI":"10.1016\/j.nbd.2020.105056","volume":"145","author":"G Cutillo","year":"2020","unstructured":"Cutillo G, Simon DK, Eleuteri S (2020) VPS35 and the mitochondria: Connecting the dots in Parkinson\u2019s disease pathophysiology. Neurobiol Dis 145:105056. https:\/\/doi.org\/10.1016\/j.nbd.2020.105056","journal-title":"Neurobiol Dis"},{"issue":"2","key":"12161_CR46","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10571-020-00849-8","volume":"41","author":"J Sassone","year":"2021","unstructured":"Sassone J, Reale C, Dati G, Regoni M, Pellecchia MT, Garavaglia B (2021) The Role of VPS35 in the Pathobiology of Parkinson\u2019s Disease. Cell Mol Neurobiol 41(2):199\u2013227. https:\/\/doi.org\/10.1007\/s10571-020-00849-8","journal-title":"Cell Mol Neurobiol"},{"issue":"8","key":"12161_CR47","doi-asserted-by":"publisher","first-page":"e70696","DOI":"10.1002\/fsn3.70696","volume":"13","author":"X Cao","year":"2025","unstructured":"Cao X, Cui X, Badehnoosh B (2025) Epigenetic Modulation and Brain Function in Parkinson\u2019s Disease: The Role of Exercise Alone or Combined With Polyphenols. Food Sci Nutr 13(8):e70696. https:\/\/doi.org\/10.1002\/fsn3.70696","journal-title":"Food Sci Nutr"},{"key":"12161_CR48","doi-asserted-by":"publisher","first-page":"1123621","DOI":"10.3389\/fcell.2023.1123621","volume":"11","author":"H Song","year":"2023","unstructured":"Song H, Chen J, Huang J, Sun P, Liu Y, Xu L, Han F (2023) Epigenetic modification in Parkinson\u2019s disease. Front Cell Dev Biology 11:1123621. https:\/\/doi.org\/10.3389\/fcell.2023.1123621","journal-title":"Front Cell Dev Biology"},{"issue":"10","key":"12161_CR49","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/s41593-020-0690-y","volume":"23","author":"LL Marshall","year":"2020","unstructured":"Marshall LL, Killinger BA, Ensink E, Li P, Li KX, Cui W, Labrie V (2020) Epigenomic analysis of Parkinson\u2019s disease neurons identifies Tet2 loss as neuroprotective. Nat Neurosci 23(10):1203\u20131214. https:\/\/doi.org\/10.1038\/s41593-020-0690-y","journal-title":"Nat Neurosci"},{"issue":"5","key":"12161_CR50","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","volume":"22","author":"A Siderowf","year":"2023","unstructured":"Siderowf A, Concha-Marambio L, Lafontant D-E, Farris CM, Ma Y, Urenia PA, Soto C (2023) Assessment of heterogeneity among participants in the Parkinson\u2019s Progression Markers Initiative cohort using \u03b1-synuclein seed amplification: a cross-sectional study. Lancet Neurol 22(5):407\u2013417. https:\/\/doi.org\/10.1016\/S1474-4422(23)00109-6","journal-title":"Lancet Neurol"},{"issue":"711","key":"12161_CR51","doi-asserted-by":"publisher","first-page":"eabo1557","DOI":"10.1126\/scitranslmed.abo1557","volume":"15","author":"R Qi","year":"2023","unstructured":"Qi R, Sammler E, Gonzalez-Hunt CP, Barraza I, Pena N, Rouanet JP, Sanders LH (2023) A blood-based marker of mitochondrial DNA damage in Parkinson\u2019s disease. Sci Transl Med 15(711):eabo1557. https:\/\/doi.org\/10.1126\/scitranslmed.abo1557","journal-title":"Sci Transl Med"},{"issue":"1","key":"12161_CR52","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/s41598-022-05227-6","volume":"12","author":"E Zago","year":"2022","unstructured":"Zago E, Dal Molin A, Dimitri GM, Xumerle L, Pirazzini C, Bacalini MG, Zago E (2022) Early downregulation of hsa-miR-144-3p in serum from drug-na\u00efve Parkinson\u2019s disease patients. Sci Rep 12(1):1330. https:\/\/doi.org\/10.1038\/s41598-022-05227-6","journal-title":"Sci Rep"},{"key":"12161_CR53","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.54337","author":"S Das","year":"2024","unstructured":"Das S, Ramteke H (2024) A Comprehensive Review of the Role of Biomarkers in Early Diagnosis of Parkinson\u2019s Disease. Cureus. https:\/\/doi.org\/10.7759\/cureus.54337","journal-title":"Cureus"},{"issue":"1","key":"12161_CR54","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13024-020-00367-7","volume":"15","author":"P Ge","year":"2020","unstructured":"Ge P, Dawson VL, Dawson TM (2020) PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson\u2019s disease. Mol Neurodegeneration 15(1):20. https:\/\/doi.org\/10.1186\/s13024-020-00367-7","journal-title":"Mol Neurodegeneration"},{"issue":"1","key":"12161_CR55","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-neuro-100720-034518","volume":"44","author":"GE V\u00e1zquez-V\u00e9lez","year":"2021","unstructured":"V\u00e1zquez-V\u00e9lez GE, Zoghbi HY (2021) Parkinson\u2019s Disease Genetics and Pathophysiology. Annu Rev Neurosci 44(1):87\u2013108. https:\/\/doi.org\/10.1146\/annurev-neuro-100720-034518","journal-title":"Annu Rev Neurosci"},{"issue":"3","key":"12161_CR56","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.gendis.2021.12.015","volume":"10","author":"Y Huang","year":"2023","unstructured":"Huang Y, Wei J, Cooper A, Morris MJ (2023) Parkinson\u2019s disease: From genetics to molecular dysfunction and targeted therapeutic approaches. Genes Dis 10(3):786\u2013798. https:\/\/doi.org\/10.1016\/j.gendis.2021.12.015","journal-title":"Genes Dis"},{"issue":"s2","key":"12161_CR57","doi-asserted-by":"publisher","first-page":"S345","DOI":"10.3233\/JPD-240155","volume":"14","author":"P Seibler","year":"2024","unstructured":"Seibler P, Streubel-Gallasch L, Klein C (2024) Combining Biomarkers with Genetics In Prodromal\/Earliest Phase Parkinson\u2019s Disease. J Parkinson\u2019s Disease 14(s2):S345\u2013S351. https:\/\/doi.org\/10.3233\/JPD-240155","journal-title":"J Parkinson\u2019s Disease"},{"issue":"5","key":"12161_CR58","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00702-020-02184-0","volume":"127","author":"J Ohnmacht","year":"2020","unstructured":"Ohnmacht J, May P, Sinkkonen L, Kr\u00fcger R (2020) Missing heritability in Parkinson\u2019s disease: the emerging role of non-coding genetic variation. J Neural Transm 127(5):729\u2013748. https:\/\/doi.org\/10.1007\/s00702-020-02184-0","journal-title":"J Neural Transm"},{"issue":"1","key":"12161_CR59","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ncrna.2023.10.007","volume":"9","author":"C Tang","year":"2024","unstructured":"Tang C, He X, Jia L, Zhang X (2024) Circular RNAs in glioma: Molecular functions and pathological implications. Non-coding RNA Res 9(1):105\u2013115. https:\/\/doi.org\/10.1016\/j.ncrna.2023.10.007","journal-title":"Non-coding RNA Res"},{"issue":"28","key":"12161_CR60","doi-asserted-by":"publisher","first-page":"4664","DOI":"10.1039\/D4AY00651H","volume":"16","author":"T Xu","year":"2024","unstructured":"Xu T, Wang Q, Wang Q, Sun L (2024) Mass spectrometry-intensive top-down proteomics: an update on technology advancements and biomedical applications. Anal Methods 16(28):4664\u20134682. https:\/\/doi.org\/10.1039\/D4AY00651H","journal-title":"Anal Methods"},{"key":"12161_CR61","doi-asserted-by":"publisher","unstructured":"Tsukita K, Sakamaki-Tsukita H, Kaiser S, Zhang L, Messa M, Serrano-Fernandez P, Takahashi R (2023) High-Throughput CSF Proteomics and Machine Learning to Identify Proteomic Signatures for Parkinson Disease Development and Progression. Neurology 101(14). https:\/\/doi.org\/10.1212\/WNL.0000000000207725","DOI":"10.1212\/WNL.0000000000207725"},{"issue":"12","key":"12161_CR62","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1002\/acn3.51234","volume":"7","author":"C Barro","year":"2020","unstructured":"Barro C, Chitnis T, Weiner HL (2020) Blood neurofilament light: a critical review of its application to neurologic disease. Ann Clin Transl Neurol 7(12):2508\u20132523. https:\/\/doi.org\/10.1002\/acn3.51234","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"12161_CR63","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s13760-023-02452-2","volume":"124","author":"H Shu","year":"2024","unstructured":"Shu H, Zhang P, Gu L (2024) Alpha-synuclein in peripheral body fluid as a biomarker for Parkinson\u2019s disease. Acta Neurol Belgica 124(3):831\u2013842. https:\/\/doi.org\/10.1007\/s13760-023-02452-2","journal-title":"Acta Neurol Belgica"},{"key":"12161_CR64","doi-asserted-by":"publisher","first-page":"1566228","DOI":"10.3389\/fneur.2025.1566228","volume":"16","author":"M Benmarce","year":"2025","unstructured":"Benmarce M, Henriksen K, Karsdal M, Holm Nielsen S (2025) Exploring Tau-C, Tau-A, and C1M as biomarkers for Parkinson\u2019s disease. Front Neurol 16:1566228. https:\/\/doi.org\/10.3389\/fneur.2025.1566228","journal-title":"Front Neurol"},{"issue":"10","key":"12161_CR65","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1212\/WNL.0000000000003680","volume":"88","author":"O Hansson","year":"2017","unstructured":"Hansson O, Janelidze S, Hall S, Magdalinou N, Lees AJ, Andreasson U, For the Swedish BioFINDER study. (2017) Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder. Neurology 88(10):930\u2013937. https:\/\/doi.org\/10.1212\/WNL.0000000000003680","journal-title":"Neurology"},{"issue":"1","key":"12161_CR66","doi-asserted-by":"publisher","first-page":"4759","DOI":"10.1038\/s41467-024-48961-3","volume":"15","author":"J H\u00e4llqvist","year":"2024","unstructured":"H\u00e4llqvist J, Bartl M, Dakna M, Schade S, Garagnani P, Bacalini M-G, Mollenhauer B (2024) Plasma proteomics identify biomarkers predicting Parkinson\u2019s disease up to 7 years before symptom onset. Nat Commun 15(1):4759. https:\/\/doi.org\/10.1038\/s41467-024-48961-3","journal-title":"Nat Commun"},{"issue":"1","key":"12161_CR67","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00401-024-02706-0","volume":"147","author":"J Rutledge","year":"2024","unstructured":"Rutledge J, Lehallier B, Zarifkar P, M Losada P, Shahid-Besanti M, Western D, L Poston K (2024) Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson\u2019s disease. Acta Neuropathol 147(1):52. https:\/\/doi.org\/10.1007\/s00401-024-02706-0","journal-title":"Acta Neuropathol"},{"issue":"10","key":"12161_CR68","doi-asserted-by":"publisher","first-page":"5307","DOI":"10.3390\/ijms25105307","volume":"25","author":"KY Kim","year":"2024","unstructured":"Kim KY, Shin KY, Chang K-A (2024) Potential Exosome Biomarkers for Parkinson\u2019s Disease Diagnosis: A Systematic Review and Meta-Analysis. Int J Mol Sci 25(10):5307. https:\/\/doi.org\/10.3390\/ijms25105307","journal-title":"Int J Mol Sci"},{"key":"12161_CR69","doi-asserted-by":"publisher","first-page":"105997","DOI":"10.1016\/j.nbd.2023.105997","volume":"177","author":"IY Abdi","year":"2023","unstructured":"Abdi IY, Bartl M, Dakna M, Abdesselem H, Majbour N, Trenkwalder C, Mollenhauer B (2023) Cross-sectional proteomic expression in Parkinson\u2019s disease-related proteins in drug-na\u00efve patients vs healthy controls with longitudinal clinical follow-up. Neurobiol Dis 177:105997. https:\/\/doi.org\/10.1016\/j.nbd.2023.105997","journal-title":"Neurobiol Dis"},{"issue":"7","key":"12161_CR70","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s10571-019-00700-9","volume":"39","author":"A Dixit","year":"2019","unstructured":"Dixit A, Mehta R, Singh AK (2019) Proteomics in Human Parkinson\u2019s Disease: Present Scenario and Future Directions. Cell Mol Neurobiol 39(7):901\u2013915. https:\/\/doi.org\/10.1007\/s10571-019-00700-9","journal-title":"Cell Mol Neurobiol"},{"issue":"16","key":"12161_CR71","doi-asserted-by":"publisher","first-page":"9299","DOI":"10.3390\/ijms23169299","volume":"23","author":"R Raghunathan","year":"2022","unstructured":"Raghunathan R, Turajane K, Wong LC (2022) Biomarkers in Neurodegenerative Diseases: Proteomics Spotlight on ALS and Parkinson\u2019s Disease. Int J Mol Sci 23(16):9299. https:\/\/doi.org\/10.3390\/ijms23169299","journal-title":"Int J Mol Sci"},{"issue":"1","key":"12161_CR72","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41531-021-00249-9","volume":"7","author":"TM Van Marques","year":"2021","unstructured":"Marques TM, Van Rumund A, Kersten I, Bruinsma IB, Wessels HJCT, Gloerich J, Verbeek MM (2021) Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach. npj Parkinson\u2019s Disease 7(1):107. https:\/\/doi.org\/10.1038\/s41531-021-00249-9","journal-title":"npj Parkinson\u2019s Disease"},{"issue":"3","key":"12161_CR73","doi-asserted-by":"publisher","first-page":"315","DOI":"10.17219\/acem\/154658","volume":"32","author":"Y-J Zhang","year":"2022","unstructured":"Zhang Y-J, Zhu W-K, Qi F-Y, Che F-Y (2022) CircHIPK3 promotes neuroinflammation through regulation of the miR-124-3p\/STAT3\/NLRP3 signaling pathway in Parkinson\u2019s disease. Adv Clin Experimental Med 32(3):315\u2013329. https:\/\/doi.org\/10.17219\/acem\/154658","journal-title":"Adv Clin Experimental Med"},{"issue":"4","key":"12161_CR74","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3233\/JPD-212726","volume":"11","author":"I Manna","year":"2021","unstructured":"Manna I, Quattrone A, De Benedittis S, Iaccino E, Quattrone A (2021) Roles of Non-Coding RNAs as Novel Diagnostic Biomarkers in Parkinson\u2019s Disease. J Parkinson\u2019s Disease 11(4):1475\u20131489. https:\/\/doi.org\/10.3233\/JPD-212726","journal-title":"J Parkinson\u2019s Disease"},{"issue":"8","key":"12161_CR75","doi-asserted-by":"publisher","first-page":"10118","DOI":"10.1007\/s12035-025-04890-w","volume":"62","author":"S Ravanidis","year":"2025","unstructured":"Ravanidis S, Bougea A, Koros C, Simitsi A-M, Kokotis P, Stefanis L, Doxakis E (2025) Plasma miRNA Biomarker Signatures in Parkinsonian Syndromes. Mol Neurobiol 62(8):10118\u201310132. https:\/\/doi.org\/10.1007\/s12035-025-04890-w","journal-title":"Mol Neurobiol"},{"issue":"22","key":"12161_CR76","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.3390\/ijms20225649","volume":"20","author":"SY Goh","year":"2019","unstructured":"Goh SY, Chao YX, Dheen ST, Tan E-K, Tay SS-W (2019) Role of MicroRNAs in Parkinson\u2019s Disease. Int J Mol Sci 20(22):5649. https:\/\/doi.org\/10.3390\/ijms20225649","journal-title":"Int J Mol Sci"},{"key":"12161_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/5374307","volume":"2020","author":"Q Lv","year":"2020","unstructured":"Lv Q, Wang Z, Zhong Z, Huang W (2020) Role of Long Noncoding RNAs in Parkinson\u2019s Disease: Putative Biomarkers and Therapeutic Targets. Parkinson\u2019s Disease 2020:1\u201312. https:\/\/doi.org\/10.1155\/2020\/5374307","journal-title":"Parkinson\u2019s Disease"},{"key":"12161_CR78","doi-asserted-by":"publisher","first-page":"763323","DOI":"10.3389\/fimmu.2021.763323","volume":"12","author":"K Honarmand Tamizkar","year":"2021","unstructured":"Honarmand Tamizkar K, Gorji P, Gholipour M, Hussen BM, Mazdeh M, Eslami S, Ghafouri-Fard S (2021) Parkinson\u2019s Disease Is Associated With Dysregulation of Circulatory Levels of lncRNAs. Front Immunol 12:763323. https:\/\/doi.org\/10.3389\/fimmu.2021.763323","journal-title":"Front Immunol"},{"key":"12161_CR79","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.omtn.2021.05.022","volume":"25","author":"AR Sharma","year":"2021","unstructured":"Sharma AR, Bhattacharya M, Bhakta S, Saha A, Lee S-S, Chakraborty C (2021) Recent research progress on circular RNAs: Biogenesis, properties, functions, and therapeutic potential. Mol Therapy - Nucleic Acids 25:355\u2013371. https:\/\/doi.org\/10.1016\/j.omtn.2021.05.022","journal-title":"Mol Therapy - Nucleic Acids"},{"issue":"9","key":"12161_CR80","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1111\/ejn.14699","volume":"53","author":"S Feng","year":"2021","unstructured":"Feng S, Wang Z, Yuan Y, Sun H, Chen N, Zhang Y (2021) Update on the association between alpha-synuclein and tau with mitochondrial dysfunction: Implications for Parkinson\u2019s disease. Eur J Neurosci 53(9):2946\u20132959. https:\/\/doi.org\/10.1111\/ejn.14699","journal-title":"Eur J Neurosci"},{"key":"12161_CR81","doi-asserted-by":"publisher","first-page":"600462","DOI":"10.3389\/fnins.2021.600462","volume":"15","author":"L Shen","year":"2021","unstructured":"Shen L, Wang C, Chen L, Wong G (2021) Dysregulation of MicroRNAs and PIWI-Interacting RNAs in a Caenorhabditis elegans Parkinson\u2019s Disease Model Overexpressing Human \u03b1-Synuclein and Influence of tdp-1. Front NeuroSci 15:600462. https:\/\/doi.org\/10.3389\/fnins.2021.600462","journal-title":"Front NeuroSci"},{"issue":"5","key":"12161_CR82","doi-asserted-by":"publisher","first-page":"e14763","DOI":"10.1111\/cns.14763","volume":"30","author":"MS Hussain","year":"2024","unstructured":"Hussain MS, Moglad E, Afzal M, Sharma S, Gupta G, Sivaprasad GV, Subramaniyan V (2024) Autophagy-associated non\u2010coding RNAs: Unraveling their impact on Parkinson\u2019s disease pathogenesis. CNS Neurosci Ther 30(5):e14763. https:\/\/doi.org\/10.1111\/cns.14763","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"12161_CR83","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12929-021-00775-x","volume":"28","author":"M-C Kuo","year":"2021","unstructured":"Kuo M-C, Liu SC-H, Hsu Y-F, Wu R-M (2021) The role of noncoding RNAs in Parkinson\u2019s disease: biomarkers and associations with pathogenic pathways. J Biomed Sci 28(1):78. https:\/\/doi.org\/10.1186\/s12929-021-00775-x","journal-title":"J Biomed Sci"},{"issue":"1","key":"12161_CR84","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10571-025-01618-1","volume":"46","author":"N Rezaei","year":"2025","unstructured":"Rezaei N, Zivari Fard M, Kazemi M, Alani B, Noureddini M, Rafiyan M, Mirzaei H (2025) Non-coding RNAs in Parkinson\u2019s Disease: Pathogenesis, Exosomes, and Therapeutic Horizons. Cell Mol Neurobiol 46(1):7. https:\/\/doi.org\/10.1007\/s10571-025-01618-1","journal-title":"Cell Mol Neurobiol"},{"issue":"3","key":"12161_CR85","doi-asserted-by":"publisher","first-page":"e13012","DOI":"10.1111\/bpa.13012","volume":"32","author":"Z Chen","year":"2022","unstructured":"Chen Z, Rasheed M, Deng Y (2022) The epigenetic mechanisms involved in mitochondrial dysfunction: Implication for Parkinson\u2019s disease. Brain Pathol 32(3):e13012. https:\/\/doi.org\/10.1111\/bpa.13012","journal-title":"Brain Pathol"},{"issue":"3","key":"12161_CR86","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/cen3.12830","volume":"16","author":"IM Praveen","year":"2025","unstructured":"Praveen IM, Calivarathan L (2025) Aberrant expression of long noncoding RNAs regulates inflammasome activation via oxidative stress: A novel mechanism for neuroinflammation and neurodegeneration in Parkinson\u2019s disease. Clin Experimental Neuroimmunol 16(3):237\u2013253. https:\/\/doi.org\/10.1111\/cen3.12830","journal-title":"Clin Experimental Neuroimmunol"},{"key":"12161_CR87","doi-asserted-by":"publisher","first-page":"106614","DOI":"10.1016\/j.intimp.2020.106614","volume":"85","author":"W Xu","year":"2020","unstructured":"Xu W, Zhang L, Geng Y, Liu Y, Zhang N (2020) Long noncoding RNA GAS5 promotes microglial inflammatory response in Parkinson\u2019s disease by regulating NLRP3 pathway through sponging miR-223-3p. Int Immunopharmacol 85:106614. https:\/\/doi.org\/10.1016\/j.intimp.2020.106614","journal-title":"Int Immunopharmacol"},{"key":"12161_CR88","doi-asserted-by":"publisher","first-page":"149838","DOI":"10.1016\/j.brainres.2025.149838","volume":"1863","author":"TL Aung","year":"2025","unstructured":"Aung TL, Kan Y, Aung YW, Shi X (2025) Meta-analysis of long non-coding RNA expression profile in Parkinson\u2019s disease. Brain Res 1863:149838. https:\/\/doi.org\/10.1016\/j.brainres.2025.149838","journal-title":"Brain Res"},{"key":"12161_CR89","doi-asserted-by":"publisher","first-page":"102327","DOI":"10.1016\/j.arr.2024.102327","volume":"98","author":"R Thapa","year":"2024","unstructured":"Thapa R, Moglad E, Afzal M, Gupta G, Bhat AA, Almalki WH, Dua K (2024) ncRNAs and their impact on dopaminergic neurons: Autophagy pathways in Parkinson\u2019s disease. Ageing Res Rev 98:102327. https:\/\/doi.org\/10.1016\/j.arr.2024.102327","journal-title":"Ageing Res Rev"},{"key":"12161_CR90","doi-asserted-by":"publisher","first-page":"155641","DOI":"10.1016\/j.prp.2024.155641","volume":"263","author":"KS Alharbi","year":"2024","unstructured":"Alharbi KS (2024) Non-coding RNAs as therapeutic targets in Parkinson\u2019s Disease: A focus on dopamine. Pathol - Res Pract 263:155641. https:\/\/doi.org\/10.1016\/j.prp.2024.155641","journal-title":"Pathol - Res Pract"},{"issue":"3","key":"12161_CR91","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s43587-021-00042-6","volume":"1","author":"F Kern","year":"2021","unstructured":"Kern F, Fehlmann T, Violich I, Alsop E, Hutchins E, Kahraman M, Keller A (2021) Deep sequencing of sncRNAs reveals hallmarks and regulatory modules of the transcriptome during Parkinson\u2019s disease progression. Nat Aging 1(3):309\u2013322. https:\/\/doi.org\/10.1038\/s43587-021-00042-6","journal-title":"Nat Aging"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12161-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12161-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12161-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:42:10Z","timestamp":1782859330000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12161-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12161"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12161-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"27 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1053"}}